| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.99e-10 | 37 | 86 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.43e-10 | 38 | 86 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.85e-09 | 35 | 86 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.95e-06 | 48 | 86 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.16e-06 | 49 | 86 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 4.37e-06 | 153 | 86 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 6.07e-06 | 28 | 86 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.24e-05 | 11 | 86 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.12e-05 | 38 | 86 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.71e-05 | 14 | 86 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.53e-05 | 211 | 86 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 8.34e-05 | 20 | 86 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 9.70e-05 | 21 | 86 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | endopeptidase activity | USP34 USP29 ERVK-8 ERVK-19 ERVK-7 ERVK-25 ERVK-9 ERVK-10 ERVK-24 | 9.73e-05 | 430 | 86 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.89e-04 | 66 | 86 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.24e-04 | 69 | 86 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.45e-04 | 288 | 86 | 7 | GO:0016757 | |
| GeneOntologyMolecularFunction | intramolecular transferase activity | 2.60e-04 | 29 | 86 | 3 | GO:0016866 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 3.50e-04 | 32 | 86 | 3 | GO:0140142 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.39e-04 | 37 | 86 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.02e-03 | 46 | 86 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.18e-03 | 107 | 86 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | peptidase activity | USP34 USP29 ERVK-8 ERVK-19 ERVK-7 ERVK-25 ERVK-9 ERVK-10 ERVK-24 | 2.00e-03 | 654 | 86 | 9 | GO:0008233 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | EPM2A LIPE FIG4 POLE NME5 ERVK-8 PLCB1 ABHD13 ERVK-7 ERVK-10 | 2.43e-03 | 807 | 86 | 10 | GO:0016788 |
| GeneOntologyMolecularFunction | steroid binding | 2.62e-03 | 133 | 86 | 4 | GO:0005496 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.61e-10 | 21 | 88 | 6 | GO:0052695 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 9.75e-10 | 12 | 88 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.09e-09 | 26 | 88 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.09e-09 | 26 | 88 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.54e-09 | 5 | 88 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 4.61e-09 | 6 | 88 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 4.61e-09 | 6 | 88 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 4.61e-09 | 6 | 88 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 6.37e-08 | 10 | 88 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 6.37e-08 | 10 | 88 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 8.82e-08 | 52 | 88 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.15e-07 | 13 | 88 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 7.46e-07 | 5 | 88 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.75e-06 | 21 | 88 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.30e-05 | 34 | 88 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.08e-05 | 13 | 88 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.51e-05 | 40 | 88 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 3.05e-05 | 286 | 88 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 3.14e-05 | 141 | 88 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 3.95e-05 | 89 | 88 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 5.13e-05 | 94 | 88 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 5.21e-05 | 48 | 88 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 8.70e-05 | 105 | 88 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.93e-04 | 67 | 88 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 3.78e-04 | 222 | 88 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 3.81e-04 | 144 | 88 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 4.08e-04 | 34 | 88 | 3 | GO:0006353 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 4.60e-04 | 84 | 88 | 4 | GO:0015800 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 4.96e-04 | 8 | 88 | 2 | GO:0070980 | |
| GeneOntologyBiologicalProcess | mature B cell differentiation involved in immune response | 5.68e-04 | 38 | 88 | 3 | GO:0002313 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | ADH7 FOXO1 LIPE UGT1A10 UGT1A8 UGT1A7 PLCB1 UGT1A9 UGT2B28 UGT2B11 | 6.62e-04 | 684 | 88 | 10 | GO:0010817 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 7.04e-04 | 94 | 88 | 4 | GO:0042440 | |
| MousePheno | reduced fertility | SLC6A6 NR2C2 LIPE SGMS1 ATXN2 STRBP USP29 PLCB1 SERPINC1 STK39 RXFP1 GRM1 ADCY3 SLX4 | 2.02e-06 | 844 | 53 | 14 | MP:0001921 |
| MousePheno | abnormal litter size | 1.67e-05 | 399 | 53 | 9 | MP:0001933 | |
| MousePheno | reduced male fertility | 4.92e-05 | 352 | 53 | 8 | MP:0001922 | |
| MousePheno | decreased litter size | 8.42e-05 | 380 | 53 | 8 | MP:0001935 | |
| MousePheno | reduced female fertility | 1.19e-04 | 296 | 53 | 7 | MP:0001923 | |
| Domain | UDPGT | 1.92e-10 | 21 | 76 | 6 | PF00201 | |
| Domain | UDPGT | 1.92e-10 | 21 | 76 | 6 | PS00375 | |
| Domain | UDP_glucos_trans | 1.92e-10 | 21 | 76 | 6 | IPR002213 | |
| Domain | IMPORTIN_B_NT | 2.28e-05 | 14 | 76 | 3 | PS50166 | |
| Domain | Importin-beta_N | 4.23e-05 | 17 | 76 | 3 | IPR001494 | |
| Domain | DZF | 1.62e-04 | 5 | 76 | 2 | SM00572 | |
| Domain | DZF_dom | 1.62e-04 | 5 | 76 | 2 | IPR006561 | |
| Domain | DZF | 1.62e-04 | 5 | 76 | 2 | PF07528 | |
| Domain | DZF | 1.62e-04 | 5 | 76 | 2 | PS51703 | |
| Domain | VitD_rcpt | 1.44e-03 | 14 | 76 | 2 | IPR000324 | |
| Domain | IBN_N | 1.66e-03 | 15 | 76 | 2 | PF03810 | |
| Domain | IBN_N | 1.89e-03 | 16 | 76 | 2 | SM00913 | |
| Domain | DSRM | 2.67e-03 | 19 | 76 | 2 | SM00358 | |
| Domain | dsrm | 2.96e-03 | 20 | 76 | 2 | PF00035 | |
| Domain | DS_RBD | 3.26e-03 | 21 | 76 | 2 | PS50137 | |
| Domain | - | 4.99e-03 | 26 | 76 | 2 | 1.25.40.90 | |
| Domain | - | 5.37e-03 | 27 | 76 | 2 | 3.30.160.20 | |
| Domain | dsRBD_dom | 5.77e-03 | 28 | 76 | 2 | IPR014720 | |
| Domain | ENTH_VHS | 6.18e-03 | 29 | 76 | 2 | IPR008942 | |
| Pathway | REACTOME_GLUCURONIDATION | 8.70e-10 | 24 | 64 | 6 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.14e-09 | 25 | 64 | 6 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.14e-09 | 25 | 64 | 6 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.14e-09 | 25 | 64 | 6 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.48e-09 | 26 | 64 | 6 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.40e-09 | 28 | 64 | 6 | M19580 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.44e-08 | 64 | 64 | 7 | M9488 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.00e-08 | 39 | 64 | 6 | MM15695 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.72e-08 | 70 | 64 | 7 | M16794 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.74e-08 | 41 | 64 | 6 | M7399 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.32e-08 | 72 | 64 | 7 | M9257 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.89e-08 | 45 | 64 | 6 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.06e-07 | 51 | 64 | 6 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.19e-07 | 52 | 64 | 6 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.68e-07 | 55 | 64 | 6 | M14933 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.56e-06 | 44 | 64 | 5 | M45014 | |
| Pathway | WP_ESTROGEN_METABOLISM | 2.66e-06 | 22 | 64 | 4 | MM15888 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 8.71e-06 | 107 | 64 | 6 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 9.69e-06 | 109 | 64 | 6 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 9.69e-06 | 109 | 64 | 6 | M18788 | |
| Pathway | BIOCARTA_MYOSIN_PATHWAY | 1.43e-05 | 11 | 64 | 3 | M7014 | |
| Pathway | REACTOME_DRUG_ADME | 1.60e-05 | 119 | 64 | 6 | MM15692 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 3.13e-05 | 14 | 64 | 3 | M39328 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.81e-05 | 219 | 64 | 7 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.98e-05 | 220 | 64 | 7 | M10320 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.94e-05 | 18 | 64 | 3 | M47659 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 8.21e-05 | 19 | 64 | 3 | MM1514 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 8.21e-05 | 19 | 64 | 3 | M3494 | |
| Pathway | WP_NRF2_PATHWAY | 4.43e-04 | 141 | 64 | 5 | M39454 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.92e-04 | 10 | 64 | 2 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M49033 | |
| Pathway | PID_RHOA_REG_PATHWAY | 1.18e-03 | 46 | 64 | 3 | M68 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.27e-03 | 178 | 64 | 5 | M2890 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 1.30e-03 | 12 | 64 | 2 | M39611 | |
| Pathway | REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK | 1.42e-03 | 49 | 64 | 3 | M27653 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.43e-03 | 183 | 64 | 5 | M39588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.53e-03 | 13 | 64 | 2 | M47656 | |
| Pathway | PID_AR_TF_PATHWAY | 1.78e-03 | 53 | 64 | 3 | M151 | |
| Pubmed | 3.59e-10 | 66 | 88 | 7 | 19898482 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 32527940 | ||
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.33e-09 | 7 | 88 | 4 | 8467709 | |
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 8464825 | ||
| Pubmed | 1.33e-09 | 7 | 88 | 4 | 27514509 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 17179145 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 20610558 | ||
| Pubmed | 2.66e-09 | 8 | 88 | 4 | 18052087 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 4.46e-09 | 94 | 88 | 7 | 21542922 | |
| Pubmed | 4.77e-09 | 9 | 88 | 4 | 22511988 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 23642732 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 11465080 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 7.94e-09 | 10 | 88 | 4 | 22558097 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 29519853 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 12847094 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.86e-08 | 12 | 88 | 4 | 20308471 | |
| Pubmed | 1.86e-08 | 12 | 88 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.86e-08 | 12 | 88 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.69e-08 | 13 | 88 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.69e-08 | 13 | 88 | 4 | 25246029 | |
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.76e-08 | 14 | 88 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 3.76e-08 | 14 | 88 | 4 | 14672974 | |
| Pubmed | 3.76e-08 | 14 | 88 | 4 | 9295054 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.25e-08 | 4 | 88 | 3 | 10469592 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 6.80e-08 | 16 | 88 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 8.88e-08 | 17 | 88 | 4 | 20639394 | |
| Pubmed | 1.14e-07 | 18 | 88 | 4 | 20056724 | ||
| Pubmed | 1.14e-07 | 18 | 88 | 4 | 18664271 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.44e-07 | 19 | 88 | 4 | 23281178 | |
| Pubmed | Multiple pathways contribute to nuclear import of core histones. | 1.56e-07 | 5 | 88 | 3 | 11493596 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 20565459 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 15057901 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 3.91e-07 | 24 | 88 | 4 | 24625756 | |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 27114554 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.30e-06 | 9 | 88 | 3 | 20732626 | |
| Pubmed | 2.55e-06 | 11 | 88 | 3 | 18695635 | ||
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 14557543 | ||
| Pubmed | A novel nuclear receptor heterodimerization pathway mediated by orphan receptors TR2 and TR4. | 6.33e-06 | 2 | 88 | 2 | 9737983 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 20688726 | ||
| Pubmed | Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | 6.33e-06 | 2 | 88 | 2 | 12185535 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25547628 | ||
| Pubmed | Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. | 6.33e-06 | 2 | 88 | 2 | 11086080 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 19131575 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22042865 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9694834 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11901093 | ||
| Pubmed | Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily. | 6.33e-06 | 2 | 88 | 2 | 12361719 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11677206 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22031623 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 12620808 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17249566 | ||
| Pubmed | Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4. | 6.33e-06 | 2 | 88 | 2 | 17431400 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 21679149 | ||
| Pubmed | Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. | 6.33e-06 | 2 | 88 | 2 | 17215859 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 6.33e-06 | 2 | 88 | 2 | 10497143 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 6.33e-06 | 2 | 88 | 2 | 17603215 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15709193 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 12944498 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9647757 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17529886 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 20089735 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 1.36e-05 | 57 | 88 | 4 | 21886157 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 12615366 | ||
| Pubmed | Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules. | 1.90e-05 | 3 | 88 | 2 | 12614157 | |
| Pubmed | A Chemical Mutagenesis Screen Identifies Mouse Models with ERG Defects. | 1.90e-05 | 3 | 88 | 2 | 26427409 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 19364970 | ||
| Pubmed | A new double-stranded RNA-binding protein that interacts with PKR. | 1.90e-05 | 3 | 88 | 2 | 10684936 | |
| Pubmed | The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. | 1.90e-05 | 3 | 88 | 2 | 9430704 | |
| Pubmed | Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices. | 1.90e-05 | 3 | 88 | 2 | 12364493 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 1.90e-05 | 3 | 88 | 2 | 20007669 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 23721685 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 19244109 | ||
| Pubmed | The TR2 and TR4 orphan nuclear receptors repress Gata1 transcription. | 1.90e-05 | 3 | 88 | 2 | 17974920 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 26247833 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 7519613 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 15738050 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 1.90e-05 | 3 | 88 | 2 | 24453052 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 19225446 | ||
| Pubmed | An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer. | 1.90e-05 | 3 | 88 | 2 | 12093744 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 23789755 | ||
| Pubmed | Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. | 1.90e-05 | 3 | 88 | 2 | 19718025 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 12606503 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 23266416 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 17406868 | ||
| Pubmed | Promoter variants of KIR2DL5 add to diversity and may impact gene expression. | 1.90e-05 | 3 | 88 | 2 | 18461314 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 19996319 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 16397224 | ||
| Pubmed | KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. | 3.79e-05 | 4 | 88 | 2 | 10820258 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 18946804 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 20484624 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 20147615 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 20180987 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 16704975 | ||
| Cytoband | 2q37 | 3.64e-07 | 31 | 87 | 4 | 2q37 | |
| Cytoband | 6q24 | 9.87e-05 | 8 | 87 | 2 | 6q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 9.25e-04 | 226 | 87 | 4 | chr2q37 | |
| Cytoband | 4q13.2 | 1.59e-03 | 31 | 87 | 2 | 4q13.2 | |
| GeneFamily | UDP glucuronosyltransferases | 1.07e-09 | 32 | 62 | 6 | 363 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.02e-05 | 18 | 62 | 3 | 596 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.71e-03 | 18 | 62 | 2 | 620 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP | 2.19e-06 | 199 | 78 | 7 | M8396 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 9.39e-06 | 163 | 77 | 5 | 2dfd11f5803822ba01b92adf4395a3b3adda68f5 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 167 | 77 | 5 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 174 | 77 | 5 | feed99acd868db61f045e666dbfdcaed91ca1488 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 180 | 77 | 5 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 180 | 77 | 5 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 1.92e-05 | 189 | 77 | 5 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| Drug | C1 11-32 | 3.01e-11 | 18 | 81 | 6 | CID000443077 | |
| Drug | C11131 | 3.01e-11 | 18 | 81 | 6 | CID000443076 | |
| Drug | AC1NOWCJ | 3.43e-11 | 35 | 81 | 7 | CID005120112 | |
| Drug | estriol-16-glucuronide | 8.73e-11 | 21 | 81 | 6 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 1.61e-10 | 23 | 81 | 6 | CID000066651 | |
| Drug | AC1N8H7N | 3.45e-10 | 78 | 81 | 8 | CID004318740 | |
| Drug | 4-hydroxyestrone | 3.90e-10 | 12 | 81 | 5 | ctd:C026418 | |
| Drug | acridine | 4.70e-10 | 81 | 81 | 8 | CID000009215 | |
| Drug | naringenin chalcone | 7.41e-10 | 5 | 81 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 7.41e-10 | 5 | 81 | 4 | ctd:C032186 | |
| Drug | 7-hydroxycoumarin glucuronide | 7.47e-10 | 29 | 81 | 6 | CID000125641 | |
| Drug | AC1Q6OQG | 1.72e-09 | 33 | 81 | 6 | CID000009686 | |
| Drug | BP-3,6-quinol | 1.72e-09 | 33 | 81 | 6 | CID000119292 | |
| Drug | 3-OH | 2.07e-09 | 61 | 81 | 7 | CID000068152 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 2.22e-09 | 6 | 81 | 4 | ctd:C543211 | |
| Drug | alloin | 2.22e-09 | 6 | 81 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 2.22e-09 | 6 | 81 | 4 | ctd:C107497 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 2.51e-09 | 35 | 81 | 6 | CID010436171 | |
| Drug | estrone-3-glucuronide | 2.51e-09 | 35 | 81 | 6 | CID000115255 | |
| Drug | l-borneol | 3.57e-09 | 37 | 81 | 6 | CID000010049 | |
| Drug | 2',4'-dihydroxychalcone | 5.16e-09 | 7 | 81 | 4 | ctd:C059354 | |
| Drug | harmol | 5.85e-09 | 40 | 81 | 6 | CID000068094 | |
| Drug | testosterone glucuronide | 6.84e-09 | 41 | 81 | 6 | CID000108192 | |
| Drug | 2,2,2-trichloroethanol | 7.47e-09 | 73 | 81 | 7 | CID000008259 | |
| Drug | androsterone glucuronide | 9.22e-09 | 43 | 81 | 6 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 9.22e-09 | 43 | 81 | 6 | CID000009191 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.03e-08 | 8 | 81 | 4 | ctd:C034890 | |
| Drug | MS-222 | 1.06e-08 | 44 | 81 | 6 | CID000011400 | |
| Drug | hexobarbital | 1.72e-08 | 127 | 81 | 8 | CID000003608 | |
| Drug | salicylamide | 1.83e-08 | 48 | 81 | 6 | CID000005147 | |
| Drug | AC1MRQNQ | 1.85e-08 | 9 | 81 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.85e-08 | 9 | 81 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 1.85e-08 | 9 | 81 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 1.85e-08 | 9 | 81 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 1.85e-08 | 9 | 81 | 4 | CID005460873 | |
| Drug | 5 alpha-androstane | 2.01e-08 | 84 | 81 | 7 | CID000094144 | |
| Drug | Hymecromone | 2.53e-08 | 25 | 81 | 5 | ctd:D006923 | |
| Drug | AC1NQGK1 | 3.00e-08 | 52 | 81 | 6 | CID005195977 | |
| Drug | 2,6-dihydroxyanthraquinone | 3.07e-08 | 10 | 81 | 4 | ctd:C034889 | |
| Drug | Scopoletin | 3.82e-08 | 27 | 81 | 5 | ctd:D012603 | |
| Drug | butylated hydroxytoluene | 4.35e-08 | 143 | 81 | 8 | CID000031404 | |
| Drug | 4-nitrophenyl)imidazole | 4.81e-08 | 11 | 81 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 4.81e-08 | 11 | 81 | 4 | CID006442661 | |
| Drug | phenolphthalein | 5.87e-08 | 58 | 81 | 6 | CID000004764 | |
| Drug | urochloralic acid | 6.51e-08 | 59 | 81 | 6 | CID003036914 | |
| Drug | 4-hydroxybiphenyl | 6.51e-08 | 59 | 81 | 6 | CID000007103 | |
| Drug | 4-hydroxyestrone | 6.51e-08 | 59 | 81 | 6 | CID000018418 | |
| Drug | acetaminophen glucuronide | 6.51e-08 | 59 | 81 | 6 | CID000083944 | |
| Drug | SN-38G | 6.51e-08 | 59 | 81 | 6 | CID000443154 | |
| Drug | N-OH-DABZ | 7.20e-08 | 12 | 81 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 7.20e-08 | 12 | 81 | 4 | CID000088735 | |
| Drug | 2,4,6-TCB | 7.20e-08 | 12 | 81 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 7.20e-08 | 12 | 81 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 7.20e-08 | 12 | 81 | 4 | CID000276709 | |
| Drug | UDP-alpha-d-xylopyranose | 7.21e-08 | 60 | 81 | 6 | CID000001165 | |
| Drug | 3-hydroxyandrostan-17-one | 7.79e-08 | 102 | 81 | 7 | CID000000225 | |
| Drug | 3-OHBaP | 9.71e-08 | 63 | 81 | 6 | CID000025890 | |
| Drug | 2-hydroxyestrone | 1.04e-07 | 13 | 81 | 4 | ctd:C024980 | |
| Drug | tritanol | 1.04e-07 | 13 | 81 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.04e-07 | 13 | 81 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.04e-07 | 13 | 81 | 4 | CID000000411 | |
| Drug | alizarin | 1.04e-07 | 13 | 81 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 1.45e-07 | 14 | 81 | 4 | CID000119515 | |
| Drug | PCB-61 | 1.45e-07 | 14 | 81 | 4 | CID000036401 | |
| Drug | Meldola | 1.54e-07 | 68 | 81 | 6 | CID000081507 | |
| Drug | hydratropic acid | 1.73e-07 | 4 | 81 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 1.73e-07 | 4 | 81 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 1.73e-07 | 4 | 81 | 3 | ctd:C037760 | |
| Drug | lithocholic acid | 1.89e-07 | 116 | 81 | 7 | CID000009903 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.97e-07 | 15 | 81 | 4 | CID000040469 | |
| Drug | afloqualone | 1.97e-07 | 15 | 81 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.97e-07 | 15 | 81 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.97e-07 | 15 | 81 | 4 | CID000010752 | |
| Drug | bergamottin | 1.97e-07 | 15 | 81 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 1.97e-07 | 15 | 81 | 4 | CID000543743 | |
| Drug | eugenol | 2.36e-07 | 73 | 81 | 6 | CID000003314 | |
| Drug | quercetin-3,4'-diglucoside | 2.62e-07 | 16 | 81 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.62e-07 | 16 | 81 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.62e-07 | 16 | 81 | 4 | CID005497144 | |
| Drug | 7-hydroxycoumarin | 2.78e-07 | 75 | 81 | 6 | CID005281426 | |
| Drug | 16-epiestriol | 3.26e-07 | 77 | 81 | 6 | CID000003269 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.42e-07 | 17 | 81 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.42e-07 | 17 | 81 | 4 | CID000037766 | |
| Drug | benzyloxyresorufin | 3.52e-07 | 78 | 81 | 6 | CID000114982 | |
| Drug | 8-azaguanine | 3.52e-07 | 78 | 81 | 6 | CID000008646 | |
| Drug | AC1L1FK5 | 3.91e-07 | 129 | 81 | 7 | CID000003272 | |
| Drug | isovaleric acid | 4.32e-07 | 5 | 81 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 4.32e-07 | 5 | 81 | 3 | ctd:C012776 | |
| Drug | Woodward's reagent K | 4.35e-07 | 43 | 81 | 5 | CID000077804 | |
| Drug | SureCN12722713 | 4.38e-07 | 18 | 81 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 4.38e-07 | 18 | 81 | 4 | CID000152226 | |
| Drug | Br 2 | 4.38e-07 | 18 | 81 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 4.38e-07 | 18 | 81 | 4 | CID000036614 | |
| Drug | ApApG | 4.38e-07 | 18 | 81 | 4 | CID003081975 | |
| Drug | 4-nitrophenol | 5.50e-07 | 45 | 81 | 5 | ctd:C024836 | |
| Drug | 9-OH-risperidone | 5.53e-07 | 19 | 81 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 5.53e-07 | 19 | 81 | 4 | CID000091433 | |
| Drug | almokalant | 5.53e-07 | 19 | 81 | 4 | CID003033962 | |
| Drug | 7-ethoxycoumarin | 6.30e-07 | 86 | 81 | 6 | CID000035703 | |
| Drug | menthol | 6.74e-07 | 87 | 81 | 6 | CID000001254 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.92e-10 | 5 | 75 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.92e-10 | 5 | 75 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.92e-10 | 5 | 75 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 1.34e-09 | 7 | 75 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.67e-09 | 8 | 75 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.80e-09 | 9 | 75 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.80e-09 | 9 | 75 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 7.99e-09 | 10 | 75 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 7.99e-09 | 10 | 75 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 7.99e-09 | 10 | 75 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 7.99e-09 | 10 | 75 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 1.25e-08 | 11 | 75 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.25e-08 | 11 | 75 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 1.25e-08 | 11 | 75 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.25e-08 | 11 | 75 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.25e-08 | 11 | 75 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.25e-08 | 11 | 75 | 4 | EFO_0010219 | |
| Disease | indole-3-carboxylate measurement | 1.58e-08 | 3 | 75 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.58e-08 | 3 | 75 | 3 | EFO_0022216 | |
| Disease | p-cresol glucuronide measurement | 1.88e-08 | 12 | 75 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.88e-08 | 12 | 75 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 2.70e-08 | 13 | 75 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 2.70e-08 | 13 | 75 | 4 | EFO_0802007 | |
| Disease | vitamin D deficiency | 3.79e-08 | 37 | 75 | 5 | EFO_0003762 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 8.93e-08 | 17 | 75 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 8.93e-08 | 17 | 75 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.15e-07 | 18 | 75 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 2.23e-07 | 21 | 75 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 3.14e-07 | 6 | 75 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 7.52e-07 | 28 | 75 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 8.71e-07 | 29 | 75 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.00e-06 | 30 | 75 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 1.87e-06 | 10 | 75 | 3 | EFO_0021015 | |
| Disease | thyroxine measurement | 2.30e-06 | 83 | 75 | 5 | EFO_0005130 | |
| Disease | cholelithiasis | 3.08e-06 | 88 | 75 | 5 | EFO_0004799 | |
| Disease | X-24588 measurement | 4.43e-06 | 13 | 75 | 3 | EFO_0800898 | |
| Disease | vitamin D measurement, COVID-19 | 7.48e-06 | 49 | 75 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 1.47e-05 | 58 | 75 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | Malignant neoplasm of skin | 1.58e-05 | 59 | 75 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 1.58e-05 | 59 | 75 | 4 | C0037286 | |
| Disease | vitamin D measurement | 2.38e-05 | 336 | 75 | 7 | EFO_0004631 | |
| Disease | temporal horn of lateral ventricle volume measurement | 3.47e-05 | 72 | 75 | 4 | EFO_0010333 | |
| Disease | p53 and DNA damage-regulated protein 1 measurement | 3.81e-05 | 4 | 75 | 2 | EFO_0803313 | |
| Disease | hormone measurement | 6.37e-05 | 84 | 75 | 4 | EFO_0004730 | |
| Disease | QRS duration | 1.13e-04 | 298 | 75 | 6 | EFO_0005055 | |
| Disease | blood molybdenum measurement | 1.25e-04 | 38 | 75 | 3 | EFO_0007582 | |
| Disease | bilirubin measurement | 1.33e-04 | 442 | 75 | 7 | EFO_0004570 | |
| Disease | gallstones | 1.69e-04 | 108 | 75 | 4 | EFO_0004210 | |
| Disease | retinal vasculature measurement | 3.46e-04 | 517 | 75 | 7 | EFO_0010554 | |
| Disease | free androgen index | 3.84e-04 | 374 | 75 | 6 | EFO_0007005 | |
| Disease | dodecanedioate measurement | 4.14e-04 | 12 | 75 | 2 | EFO_0021054 | |
| Disease | Charcot-Marie-Tooth Disease | 4.14e-04 | 12 | 75 | 2 | C0007959 | |
| Disease | melanoma | 4.31e-04 | 248 | 75 | 5 | C0025202 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.40e-04 | 58 | 75 | 3 | C0002736 | |
| Disease | non-high density lipoprotein cholesterol measurement | 4.53e-04 | 713 | 75 | 8 | EFO_0005689 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 5.46e-04 | 147 | 75 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 5.61e-04 | 63 | 75 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 9.50e-04 | 18 | 75 | 2 | EFO_0010365 | |
| Disease | phosphatidylcholine 36:4 measurement | 9.50e-04 | 18 | 75 | 2 | EFO_0010382 | |
| Disease | response to clozapine | 9.50e-04 | 18 | 75 | 2 | GO_0097338 | |
| Disease | urate measurement, bone density | 1.00e-03 | 619 | 75 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Leukemia, Myelocytic, Acute | 1.00e-03 | 173 | 75 | 4 | C0023467 | |
| Disease | receptive language perception | 1.06e-03 | 19 | 75 | 2 | EFO_0005686 | |
| Disease | mean platelet volume | 1.11e-03 | 1020 | 75 | 9 | EFO_0004584 | |
| Disease | testosterone measurement | ZNF438 FZD7 LIPE UGT1A10 UGT1A8 UGT1A7 HLF PLCB1 UGT1A9 UGT2B11 | 1.41e-03 | 1275 | 75 | 10 | EFO_0004908 |
| Disease | apolipoprotein B measurement | 1.48e-03 | 663 | 75 | 7 | EFO_0004615 | |
| Disease | eye measurement | 2.15e-03 | 27 | 75 | 2 | EFO_0004731 | |
| Disease | serum gamma-glutamyl transferase measurement | 2.22e-03 | 914 | 75 | 8 | EFO_0004532 | |
| Disease | Ischemic stroke, factor VII measurement | 2.48e-03 | 29 | 75 | 2 | EFO_0004619, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSDQLIPPVMMKQLY | 266 | Q7L211 | |
| IPPVMMKQLYELSPS | 271 | Q7L211 | |
| VPPSAKMLTYDPMLL | 306 | P40394 | |
| MTPMRDKPKQEYLNP | 1151 | Q15303 | |
| VMAQRQPMKPTYAIP | 286 | Q9H2F5 | |
| DMIPTEMQRLTKYPL | 556 | Q92888 | |
| PDRTTLYSLMMKPIQ | 551 | O15013 | |
| PEYPFKTKQMMSPVS | 311 | Q8IY63 | |
| MLHEMVKPYPAPQPV | 341 | Q8IY63 | |
| TAKPRDIPMNPMCIY | 41 | P01008 | |
| FRLTMPSPMPEYLNV | 376 | P13056 | |
| HVTFKLTMPSPMPEY | 366 | P49116 | |
| PPTDTTMYMELPNAK | 321 | Q8N109 | |
| AVAGPLPTMYQIPEM | 2331 | Q04721 | |
| LPTMYQIPEMARLPS | 2336 | Q04721 | |
| VMSKAAYMPIRLPAP | 136 | Q8NH95 | |
| NRYPEPMTPDTMIKL | 206 | O95278 | |
| LPGFPMKIDIPSLMY | 191 | Q9BYJ1 | |
| LYPIPMTPMPVNQAK | 981 | Q99700 | |
| SLNLPPVTMSGKYIM | 3046 | Q2LD37 | |
| PPTDTTMYMELPNAK | 321 | Q8NHK3 | |
| RTPVQPNPIVYMMKA | 16 | O96000 | |
| MEISMPPPQIYVEKT | 1 | P56597 | |
| MALPPSPLAMEYVND | 1 | P54845 | |
| ICSPISLPEKIMYPM | 126 | Q5FWF7 | |
| KMPTMVPLSLLSVPQ | 226 | P56270 | |
| PKVTISYPGAMLNIM | 886 | Q07864 | |
| MEKMSRPLPLNPTFI | 1 | Q16534 | |
| QYLPVVMGPLMKTAS | 621 | O00410 | |
| ICKPLRYPMIMSQTV | 126 | Q8NH89 | |
| PSSEKLPVMYLMDSI | 66 | O94913 | |
| APVYPIMVQLLQKAM | 821 | Q9UP83 | |
| PPMSPDFTVFMIKYL | 521 | O75084 | |
| MVYPPSAAKMASTLP | 346 | Q12778 | |
| MPMASPQTLVLYLLV | 1 | Q96T91 | |
| ISTMMPKPPITLDQA | 336 | Q92562 | |
| PSPPLMSYITSQEMK | 26 | Q9NWQ9 | |
| PSTTYAITPMKRPME | 361 | Q12906 | |
| DRLPLVPSKYSMTVM | 831 | O60266 | |
| LMPIPTPLIMSDYQE | 66 | Q30KR1 | |
| YLMPLNTSIVMPPKN | 161 | O43736 | |
| THSKPLAPMELEPMY | 636 | Q96P31 | |
| LAPMELEPMYSNVNP | 641 | Q96P31 | |
| YLEKPVVPLNMMLPQ | 236 | Q9NWL6 | |
| QMPLVAPVILPEMYK | 181 | Q96P70 | |
| MLLNVIYPPMSILPN | 1136 | Q8NDH2 | |
| PMVYMNDKSPLTPEK | 831 | Q14289 | |
| MKPPAMTQYQTPLFV | 171 | P00395 | |
| GMLMPPFIPDSKTVY | 466 | Q15835 | |
| IMEPPMPILSYPSIK | 726 | Q13255 | |
| MQTEIKLRPPYQISM | 141 | Q96IW7 | |
| QMPLYSSPIVKNPFM | 956 | Q05469 | |
| MPPTMNPIVYGVKTR | 286 | Q8NH53 | |
| QSMTSDPYIKMTILP | 186 | Q9H2B2 | |
| MLYSMLQGLDTVPVP | 361 | Q9BZE2 | |
| FIAYPKAVTMMPLPT | 371 | P31641 | |
| EQIAMLPPPAVMNYI | 36 | Q96AM1 | |
| IPFVAPPLVMLMTKT | 106 | Q5SWH9 | |
| PPLVMLMTKTYIPIL | 111 | Q5SWH9 | |
| SNIAYPKLVMALMPV | 366 | Q2M3M2 | |
| ILYPRPKSLLPKMMN | 66 | Q9UIL1 | |
| KRMVLLPVMKFPTYP | 651 | Q96SI9 | |
| MMAKNKEPRPPSYTI | 1 | Q13017 | |
| PKVPITPMPQYSIME | 1556 | Q8IY92 | |
| TPMPQYSIMETPVLK | 1561 | Q8IY92 | |
| LSTMPVLYMIVSLPP | 646 | Q8TDI8 | |
| KKGDTVVIYMPMIPQ | 166 | Q9H6R3 | |
| PVMTQPTLIYSQPVM | 621 | Q13492 | |
| PPAMQKVMYKGLVPE | 121 | O14562 | |
| MPAPLYSPTSQKIMT | 106 | P63127 | |
| DFVLDYPKPVMPNMI | 256 | Q9HAW8 | |
| MPAPLYSPTSQKIMT | 106 | P63129 | |
| VMTPPPVHYLQFKEM | 626 | Q5VZE5 | |
| SPVVPLMLYMPAKIG | 466 | O15270 | |
| MPAPLYSPTSQKIMT | 106 | P63121 | |
| PQKMMLYPVLSLATV | 211 | Q9BTD3 | |
| MPAPLYSPTSQKIMT | 106 | P63131 | |
| MPAPLYSPTSQKIMT | 106 | P63125 | |
| PSYQKMPLFMSKSPT | 141 | Q9HBJ7 | |
| QEMPPELMKPDLFTY | 726 | Q9HBX9 | |
| IKIPMPELERSQYPM | 116 | Q86VZ5 | |
| MLRVLYPPKTPTMMV | 1526 | Q9BZZ2 | |
| DFVLDYPKPVMPNMI | 256 | O60656 | |
| PSYIPIVMSKLSDQM | 191 | O75310 | |
| MPAPLYSPTSQKIMT | 106 | P10265 | |
| PLPSPMDLMYKILVK | 451 | Q9NQ66 | |
| KPEYIQMLMPPLIQK | 566 | Q92973 | |
| QPAGLPDKMTIEMYP | 1216 | Q70CQ2 | |
| PSYIPVVMSKLSDQM | 191 | Q9BY64 | |
| MPAPLYSPTSQKIMT | 106 | P63122 | |
| YPPMKVLMLTLQNDP | 276 | Q9UEW8 | |
| KLPIPPYSRMKTMEV | 291 | Q7Z4V0 | |
| DFVLEYPKPVMPNMI | 256 | Q9HAW7 | |
| DFVLDYPKPVMPNMI | 256 | Q9HAW9 | |
| MPAPLYSPTSQKIMT | 106 | P63124 | |
| MPAPLYSPTSQKIMT | 106 | P63120 | |
| MLYLLSLMQPKPGAP | 436 | P59046 | |
| MVRNTYIFPPEPSMK | 226 | P22033 |